Every year, over the last five years, the hospital has run 10 international trials, according to the company.
“With the Clinerion database system, there will be a great progress in research at our center, facilitating patient selection and increasing our effectiveness. Today, a database and facilitating access to information are fundamental to the evolution of research,” said Dalton Precoma, MD, PhD, cardiologist at Hospital Angelina Caron, in a statement.
Said Ian Rentsch, CEO of Clinerion: “We are so pleased that our patient coverage in Brazil is expanding by leaps and bounds. It shows that the benefits of visibility to pharmaceutical trial sponsors that we offer to hospitals running international clinical trials are well understood and accepted.”
Clinerion has made several additions to its Patient Network Explorer platform so far this year, including in Greece, India, Poland, and Georgia.
The platform uses data from electronic health records (EHRs) for clinical trial patient recruitment and real-world evidence (RWE) generation.
Clinerion also recently announced that it is deploying Volv’s AI algorithms across its hospital network as part of a strategic collaboration that includes plans to bring an ‘enhanced value proposition’ to both companies’ expanded client base, Volv CEO, Chistopher Rudolf, told us at the time.
